Back to CGEM
TCG Crossover Management, LLC → CGEM
TCG Crossover Management, LLC CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
3
Latest value
$6.2M
Q3 2026
Peak value
$7.4M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $5.8M |
| Q2 2026 | $7.4M |
| Q3 2026 | $6.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.2M | 406.8K | — | — |
| Q2 2026 | $7.4M | 406.8K | — | — |
| Q1 2026 | $5.8M | 406.8K | — | — |
Other funds holding CGEM
$177.2M
$163.2M
$163.2M
$149.2M
$137.6M
$127.4M
$108.7M
$104.7M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC